Statistiken für The PROPER Study: A 48-Week, Pan-European, Real-World Study of Biosimilar SB5 Following Transition from Reference Adalimumab in Patients with Immune-Mediated Inflammatory Disease
Aufrufe insgesamt
| views | |
|---|---|
| The PROPER Study: A 48-Week, Pan-European, Real-World Study of Biosimilar SB5 Following Transition from Reference Adalimumab in Patients with Immune-Mediated Inflammatory Disease | 5 |
Aufrufe pro Monat
| views | |
|---|---|
| Januar 2024 | 0 |
| Februar 2024 | 3 |
| März 2024 | 0 |
| April 2024 | 0 |
| Mai 2024 | 1 |
| Juni 2024 | 1 |
| Juli 2024 | 0 |
Datei-Aufrufe
| views | |
|---|---|
| 10.1007_s40259-023-00616-3.pdf | 4 |
Top-Länder-Aufrufe
| views | |
|---|---|
| Deutschland | 2 |
| Vereinigte Staaten | 2 |
| Indonesien | 1 |
Top-Städte-Aufrufe
| views | |
|---|---|
| Jakarta | 1 |
| San Francisco | 1 |